Alta Partners — Full Portfolio

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)inAlan Fuhrman(Executive Officer)inTHTodd Harris(President, Chief Executive Officer and Director)inBhavesh Ashar(Chief Operating Officer)in

Co-investorsBIBioBritNENextech InvestCACanaan PartnersRARA Capital

Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

MDMarianne De Backer(CEO)inHerbert Virgin(Executive Officer)Howard Horn(Executive Officer)inABAlex Bangs(Executive Officer)inMarianne De Backer, M.Sc., Ph.D., MBA(President, Chief Executive Officer and Director)

BoardGSGeorge Scangos(Executive Officer, Director)

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)SOSoftBank Vision Fund8V8VCALALTITUDE LIFE SCIENCE VENTURESDCDCVC (Data Collective)+1 more

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtechSan Carlos, US

AFAnthony Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)LRLiam Ratcliffe(Director)in

BoardRHRon Hunt(Director)inLoretta Tse, Ph.D.(Director)

Co-investorsLOLongitude CapitalABabrdn plcINIntermediate Capital GroupJOJohnson & Johnson Innovation – JJDCNENew Leaf Venture PartnersPAPappas Capital+2 more

Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.

BiotechSan Carlos, US

Nenad Tomasevic(Executive Officer)Christopher Bebbington(Executive Officer, Director)Alejandro Dorenbaum(Executive Officer)

BoardJMJohn McKearn(Director)inPeter Moldt(Director)

Board seatDan JanneyFCFarah Champsi· per SEC Form D

Co-investorsLILifeSci Venture PartnersNENew Enterprise Associates (NEA)RIRiverVest Venture PartnersSASamsara BioCapitalRORoche Venture Fund

Berkeley, US

PCPeter Calthorpe(Executive Officer, Director)in

Board seatGarrett Gruener· per SEC Form D · $2M raise · filed Jul 2019

Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions.

BiotechHealthtechMedical DevicesPittsburgh, US

SKSuma Krishnan(President, Research & Development)inKKKrish Krishnan(Chairman & CEO)inDoug Norby(Director)Dino Rossi(Director)

Board seatDan Janney· per SEC Form D · $11.3M raise · filed Aug 2017

Co-investorsAVAvoro Capital AdvisorsFRFrazier Life Sciences

Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells.

BiotechDeep TechMedical DevicesWatertown, US

DHDmitrij Hristodorov(Director)inChristopher Loose(Executive Officer, Director)Sanjay Magavi(Executive Officer)MTMarc-Olivier Turgeon(Director)in

BoardARAleks Radovic-Moreno(Director)in

Board seatDan Janney· per SEC Form D

Co-investorsDODolby Family VenturesLOLongwood FundMIMission BiocapitalSEService Provider CapitalFOForbion

Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units.

BiotechHealthtechMedical DevicesCity Of Industry, US

SEScott Elster(Executive Officer, Director)inJMJohn M. Shields(Executive Officer)in

BoardFFFrank Foster(Director)MSMartin Sutter(Director)David Brailer(Director)

Board seatDan Janney· per SEC Form D

Co-investorsAIAisling CapitalESEssex Woodlands Healthcare PartnersFRFrontier Venture CapitalPRPROOF

Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

HPHugo Peris(Founder & CEO)inEDEugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)

BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)

Board seatGNGuy Nohra· per SEC Form D · $10.9M raise · filed Feb 2023

Co-investorsCACatalio Capital ManagementINInveready Technology Investment GroupLILifelinkSTStartXCACamden PartnersESEsperante Ventures

USGI Medical develops endoluminal medical devices that enable surgical procedures without incisions, targeting healthcare providers and patients seeking less invasive treatment options.

HardwareHealthtechMedical DevicesSan Clemente, US

TMTracy Maahs(Executive Officer)inScott Moonly(Executive Officer, Director)inJCJohn Cox(Executive Officer)in

BoardMike Chuisano(Director)George Abi-Chahine(Director)

Board seatGNGuy Nohra· per SEC Form D · $4M raise · filed Jun 2019

Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease.

BiotechHealthtechMedical DevicesBedminster, US

CASEY KOPCZYNSKI(Executive Officer)inVICENTE ANIDO(Executive Officer, Director)BLBRIAN LEVY(Executive Officer)RICHARD RUBINO(Executive Officer)THOMAS MITRO(Executive Officer)DEDavid Endicott(CEO of Alcon)in

Co-investorsAVAvoro Capital AdvisorsFOForesite CapitalOUOUP (Osage University Partners)SOSofinnova Ventures

Amplitude Therapeutics is a biotechnology company developing RNA-based medicines.

Biotech

Ark provides a customizable digital platform for venture capital and private equity firms to manage investor communications, performance reporting, and document sharing with their limited partners.

Enterprise SoftwareFintechSaaS

Bill Ward(Chief Executive Officer)

Co-investorsACAcies InvestmentsALAloft VCAMAmity VenturesARArtis VenturesASAsymmetric Capital PartnersATAt One Ventures+21 more

Boston, US

Dan Adams(Executive Officer, Director)

BoardPete Hudson(Director)inBruce Herzfelder(Director)Mark Prather(Director)

Bioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures.

BiotechDeep TechHealthtechMedical DevicesDurham, US

RCRobert Claypoole(Chief Executive Officer)

Co-investorsAMAmpersandESEssex Woodlands Healthcare Partners

Calistoga Pharmaceuticals is a pharmaceutical company.

BiotechHealthtechSeattle, US

Co-investorsFRFrazier Life SciencesAMAmgen VenturesFRFrazier Healthcare Partners

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical DevicesDurham, US

Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)

Co-investorsAIAisling CapitalASAsset Management CompanyCACanaan PartnersFRFrazier Life SciencesPAPappas CapitalSASanderling Ventures

DEM BioPharma is a biotechnology company developing cancer therapies by targeting the immune system, drawing on genetic and immuno-oncology research.

BiotechHealthtechCambridge, US

NGNenad Grmusa(Chief Executive Officer)inJMJohn McCabe(Chief Financial and Operating Officer)in

Co-investorsASAstellas Venture Management LLCDCDC Investment PartnersLOLongwood FundPFPfizer Venture InvestmentsUTUTokyo Innovation Platform Co. Ltd.INInsight Partners+1 more

DispatchHealth delivers in-home medical care and house call services, offering patients an alternative to emergency rooms and urgent care facilities for acute medical conditions.

Digital HealthHealthtechDenver, US

DMDr. Mark Prather(Founder)KRKevin Riddleberger(Founder)inJennifer Webster(CEO)Dominic Bagnoli(Director)Mark Prather(Founder)

BoardPete Hudson(Director)in

Co-investorsECEcho Health VenturesOAOak HC/FTOPOptum VenturesQUQuesta CapitalSISINEWAVE VENTURESTITiger Global Management

Edgewood Oncology is a clinical-stage biotechnology company developing BTX-A51, a first-in-class treatment candidate for hematologic malignancies and genetically-defined solid tumors.

BiotechHealthtechMedical Devices

YBYinon Ben-Neriah(Scientific Founder)DNDavid N. Cook(Chief Executive Officer)inZTZung Thai(Chief Medical Officer)in

eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.

BiotechDeep TechMedical Devices

MCMike Curtis, Ph.D.(President & Chief Executive Officer)George M. Church(Founder)Luhan Yang(Founder)

Co-investorsALAltium CapitalEIEisai Innovation, Inc.FRFresenius Medical Care VenturesKHKhosla VenturesLULux CapitalARARCH Venture Partners

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

BoardGMGeorge M. Church(Director)

Co-investorsARARCH Venture PartnersCACatalio Capital Management, LPHBHBM Healthcare InvestmentsHBHBM PartnersKHKhosla VenturesLILifeSci Venture Partners+12 more

Biopharma developing HDL-C regulating therapies; listed 2000.

BiotechAnn Arbor, US

Roger S. Newton(Director)inTim M. Mayleben(Executive Officer, Director)

BoardDaniel Janney(Director)Dov A. Goldstein(Director)NVNicole Vitullo(Director)inPEPatrick Enright(Director)in

PartnerDan Janney· led

Co-investorsAIAisling CapitalARArboretum VenturesARARCHIMED JapanASAsset Management CompanyCACanaan PartnersHEHealthCap+3 more

Everside is a venture capital and investment firm that manages portfolios and provides investment operations, analytics, and advisory services.

Enterprise SoftwareFintechSector Agnostic

MPMoritz Poehl(Founder, Managing Partner)inNKNate Kirk(Founder, Managing Partner)in

Co-investorsINInterplay Ventures Early Stage Management LlcENEndeavor CatalystNENew Enterprise Associates (NEA)OAOak HC/FT

Marathon Health provides advanced primary care combined with lifestyle and chronic condition management for employers and health plans, using health coaches and registered dietitians alongside providers.

Digital HealthHealthtechWellness & Fitness

Dr. Jeff Wells(Founder)

Co-investorsHEHercules Capital, Inc.NENew Enterprise Associates (NEA)SISixty Degree CapitalENEndeavor CatalystOAOak HC/FT

Free Market Health operates a care-driven marketplace platform for the specialty pharmacy ecosystem.

B2B MarketplacesHealthtechSaaSPittsburgh, US

JCJoe Cardosi(Founder)in

Co-investorsQUQuesta Capital

Harbor provides electronic data capture (EDC) software for clinical trial teams, designed to reduce data entry time and enable remote monitoring to improve data quality and accelerate trial timelines.

HealthtechMedical DevicesSaaSSan Francisco, US

ACAlbert Cai(CEO)inNHNathan H. Leung(CTO)inArisa Amano(Founder)Bob Remeika(Founder)

Co-investors8V8VCCOCore Venture CapitalY Y CombinatorCOCommit CapitalDFDFOFUFuture Perfect Ventures+5 more

Harbor Plan provides automation software for independent professionals to manage their practices.

AI & Machine LearningFintechSaaSSales TechSan Francisco, US

CAClinton A.(Managing Director)inRCRob Carrington(Head of Engineering)in

Co-investorsTETechstarsTITinySeed8V8VCDFDFOGEGeneral Catalyst

Crypto & Web3Enterprise SoftwareFintechSioux Falls, US

Co-investorsANAndreessen HorowitzFUFuture Perfect VenturesKIKindred VenturesPAPantera CapitalSISignia Venture Partners8V8VC+3 more

Harbor provides sleep training and infant care services for parents and families seeking better sleep and wellness support.

AI & Machine LearningConsumerHardwareHealthtechIoTWellness & Fitness

Kelly Brown(Director of Nursing)Lindsey Sullivan(Chief Marketing Officer)

Co-investorsCACarnrite Ventures8V8VCDFDFOGEGeneral CatalystTRTrust Ventures

Harbor Health is a healthcare provider and insurance company operating clinics across Texas that offers primary care, specialty care, and health coaching alongside integrated insurance coverage.

HealthtechInsurTechAustin, US

Sterling Claiborne Johnston(Chief Medical Officer)Jeffrey Fisher(Chief Financial Officer)ESEric Scott(Vice President)inKRKara Rios(Chief Financial Officer)inClay Johnston(Founder)Tony Miller(Founder)

Co-investors8V8VCCUCubit CapitalGEGeneral CatalystHEHealth2047 Capital Partners LLCLELemhi VenturesMAMartin Ventures+2 more

Immunotherapy oncology company engineering technologies to activate the immune system; acquired by Merck in February 2019 for $0.3B.

BiotechHealthtechMedical DevicesSeattle, US

DBDavid Baltimore(Director)Carlos V. Paya(Executive Officer, Director)Stephen R. Brady(Executive Officer)inJHJan Henrik ter Meulen(Executive Officer)Paul Rickey(Executive Officer)inWayne Gombotz(Executive Officer)in

Co-investorsAIAisling CapitalATAtlas VentureHMHM Venture PartnersOUOUP (Osage University Partners)SASanderling VenturesSASanofi Ventures+4 more

Biopharmaceutical company developing innovative therapies for chronic diseases using proprietary drug delivery systems.

BiotechBoston, US

James Ahlers(Executive Officer)John Yee(Executive Officer)Sunita Zalani(Executive Officer)Raymond T. Keane(Executive Officer)Thomas Alessi(Executive Officer)Owen Hughes, Jr.(Executive Officer)

Co-investorsBABay City CapitalCLCloudStone CapitalCYCycad Group LLCFOForesite CapitalMAMarkerNXNXT Ventures+3 more

Kelonia is a biotechnology company developing next-generation genetic medicines, with a focus on cell and gene therapy programs including in vivo approaches and oncology applications.

BiotechHealthtech

KFKevin Friedman(Founder & Chief Executive Officer)in

Co-investorsHOHorizons Ventures

Kite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells.

BiotechHealthtechSanta Monica, US

ASArie S. Belldegrun(Executive Officer, Director)inMargo R. Roberts(Executive Officer)CBCynthia Butitta(Executive Officer)inMBMarc Better(Executive Officer)inRizwana Sproule(Executive Officer)inArie Belldegrun(Founder)

Co-investorsPOPontifax Venture CapitalVIVida Ventures

Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.

Biotech

DKDavid King(Co-Founder & CSO)inMFMaria Fardis(CEO)inCCCadmus C. Rich(Chief Medical Officer)inESElaine Stracker(General Counsel)in

Co-investorsCACatalio Capital Management, LPDCDC Investment PartnersFRFrazier Life SciencesLOLongitude CapitalLOLongwood FundBIBiotechnology Value Fund+2 more

Marathon Health provides an advanced primary care model to employers through onsite, nearsite, network, and virtual health centers, aiming to improve employee health and lower healthcare costs.

Digital HealthHealthtechWellness & Fitness

Jeff Wells(CEO)Jerry Ford(Founder)Rick Ennis(Founder)

Co-investorsGEGeneral AtlanticNENew Enterprise Associates (NEA)OAOak HC/FTPOPotentum PartnersSISixty Degree Capital

mBrace Therapeutics is a therapeutics company focused on drug development, led by executives with backgrounds in oncology and pharmaceutical business development.

BiotechHealthtech

Jay(Executive (former VP, Head of BD&A at AbbVie))Isan Chen(Founder)Renata Pasqualini(Founder)Wadih Arap(Founder)

Co-investorsVEVenrock

South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.

Daly City, US

Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)

BoardElizabeth Stanley(Director)

Co-investorsCECerity Partners VenturesCOColorcon Ventures5A5AM VenturesALAlexandriaDCDCVC (Data Collective)DCDCVC Bio+2 more

Digital HealthHealthtechWellness & Fitness

PatientsLikeMe is a digital health platform where over 850,000 members with various health conditions share experiences and insights to help each other manage their health.

Digital HealthHealthtechSocialCambridge, US

Philippe Amouyal(Director)Jonathan White(Director)Justin Barstein(Director)Martin Coulter(Executive Officer, Director)Jay M. Tenenbaum(Director)Stephen Heywood

Co-investorsOPOptum Ventures

Hangzhou-based gene-editing biotech developing immune-privileged cell therapies and xenogeneic organs for transplant and cancer.

Hangzhou, CN

Luhan Yang, PhD(Co-Founder and Chief Executive Officer)George Church, PhD(Co-founder and Co-Chair of Qihan scientific advisory groups)

Co-investorsARARCH Venture PartnersLALAVSESequoia Capital

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)

Co-investorsANAndreessen HorowitzARARCH Venture PartnersGVGV (Google Ventures)LULuma GroupSASanofi VenturesABAbingworth+11 more

Brendan Eckelman(Founder)

Co-investorsVEVenrock

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.

AI & Machine LearningDigital HealthHealthtechDenver, US

GTGlen Tullman(Founder)in

Co-investors7W7wire VenturesCOCorewell Health VenturesGEGeneral CatalystGEGeodesic CapitalGRGreatPoint VenturesHUHuman Capital+9 more

UMP is a musculoskeletal (MSK) managed service organization that partners with independent physicians to handle administrative operations while preserving clinical autonomy.

Digital HealthEnterprise SoftwareHealthtechAtlanta, US

Raj Bholé(Founding Physician Director)

Co-investorsWCWCAS

Variant Bio is a therapeutics company that uses human genomics to guide drug development, drawing on expertise across genetics, molecular biology, therapeutics, anthropology, and ethics.

AI & Machine LearningBiotechDigital HealthNew York, US

KWKaja Wasik(Founder)inAFAndrew Farnum(Founder)inSCStephane Castel(Founder)inCraig Basson(Chief Medical Officer, President of R&D)inHVHolly Vance(Chief Operating Officer)in

BoardJulie Sunderland(Director)

Co-investorsGEGeneral CatalystLULux CapitalSOSoftBank Vision FundDIDimension Capital